Skip to main content
Top
Published in: Current HIV/AIDS Reports 1/2014

01-03-2014 | The Science of Prevention (SC Kalichman, Section Editor)

Antiretroviral Adherence Interventions in Southern Africa: Implications for Using HIV Treatments for Prevention

Authors: Sarah Dewing, Cathy Mathews, Geoffrey Fatti, Ashraf Grimwood, Andrew Boulle

Published in: Current HIV/AIDS Reports | Issue 1/2014

Login to get access

Abstract

There is concern that the expansion of ART (antiretroviral treatment) programmes to incorporate the use of treatment as prevention (TasP) may be associated with low levels of adherence and retention in care, resulting in the increased spread of drug-resistant HIV. We review research published over the past year that reports on interventions to improve adherence and retention in care in Southern Africa, and discuss these in terms of their potential to support the expansion of ART programmes for TasP. We found eight articles published since January 2012, seven of which were from South Africa. The papers describe innovative models for ART care and adherence support, some of which have the potential to facilitate the ongoing scale- up of treatment programmes for increased coverage and TasP. The extent to which interventions from South Africa can be effectively implemented in other, lower-resource Southern African countries is unclear.
Footnotes
1
Coverage was defined in this study as the proportion of all HIV-infected individuals receiving ART [7].
 
Literature
2.
go back to reference Goga A, Dinh T-H, Dlamini N, et al. Impact of the national prevention of mother to child transmission (PMTCT) program on mother-to-child transmission of HIV (MTCT), South Africa, 2010. In: 6th IAS Conference on Pathogenesis, Treatment and Prevention. Rome, Italy; 2011. Goga A, Dinh T-H, Dlamini N, et al. Impact of the national prevention of mother to child transmission (PMTCT) program on mother-to-child transmission of HIV (MTCT), South Africa, 2010. In: 6th IAS Conference on Pathogenesis, Treatment and Prevention. Rome, Italy; 2011.
3.
go back to reference Kim MH, Ahmed S, Preidis GA, et al. Low Rates of Mother-to-Child HIV Transmission in a Routine Programmatic Setting in Lilongwe, Malawi. PLoS One. 2013;8:e64979.PubMedCentralPubMedCrossRef Kim MH, Ahmed S, Preidis GA, et al. Low Rates of Mother-to-Child HIV Transmission in a Routine Programmatic Setting in Lilongwe, Malawi. PLoS One. 2013;8:e64979.PubMedCentralPubMedCrossRef
4.
go back to reference Mofenson LM. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Committee on Pediatric Aids. Pediatrics. 2000;106:E88.PubMedCrossRef Mofenson LM. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Committee on Pediatric Aids. Pediatrics. 2000;106:E88.PubMedCrossRef
6.
go back to reference Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9:e1001245.PubMedCentralPubMedCrossRef Eaton JW, Johnson LF, Salomon JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9:e1001245.PubMedCentralPubMedCrossRef
7.
go back to reference Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–71.PubMedCrossRef Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966–71.PubMedCrossRef
8.
go back to reference Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, et al. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res. 2011;9:446–69.PubMedCentralPubMedCrossRef Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, et al. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res. 2011;9:446–69.PubMedCentralPubMedCrossRef
9.
go back to reference McNairy ML, Howard AA, El-Sadr WM. Antiretroviral Therapy for Prevention of HIV and Tuberculosis: a Promising Intervention but Not a Panacea. J Acquir Immune Defic Syndr. 2013;63 Suppl 2:S200–7.PubMedCrossRef McNairy ML, Howard AA, El-Sadr WM. Antiretroviral Therapy for Prevention of HIV and Tuberculosis: a Promising Intervention but Not a Panacea. J Acquir Immune Defic Syndr. 2013;63 Suppl 2:S200–7.PubMedCrossRef
10.
go back to reference World Health Organization. Antiretroviral treatment as prevention (TasP)of HIV and TB: 2012 Update. Geneva: World Health Organization; 2012. World Health Organization. Antiretroviral treatment as prevention (TasP)of HIV and TB: 2012 Update. Geneva: World Health Organization; 2012.
11.
go back to reference Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.PubMedCrossRef Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357–66.PubMedCrossRef
12.
go back to reference Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146:564–73.PubMedCrossRef Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146:564–73.PubMedCrossRef
13.
go back to reference Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–3.PubMedCrossRef Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15:1181–3.PubMedCrossRef
14.
go back to reference Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21:965–71.PubMedCrossRef Oyugi JH, Byakika-Tusiime J, Ragland K, et al. Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda. AIDS. 2007;21:965–71.PubMedCrossRef
15.
go back to reference Barnighausen T, Tanser F, Dabis F, Newell ML. Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS. 2012;7:140–50.PubMedCrossRef Barnighausen T, Tanser F, Dabis F, Newell ML. Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence. Curr Opin HIV AIDS. 2012;7:140–50.PubMedCrossRef
16.
go back to reference Wandeler G, Keiser O, Pfeiffer K, et al. Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr. 2012;59:e9–e16.PubMedCentralPubMedCrossRef Wandeler G, Keiser O, Pfeiffer K, et al. Outcomes of antiretroviral treatment programs in rural Southern Africa. J Acquir Immune Defic Syndr. 2012;59:e9–e16.PubMedCentralPubMedCrossRef
17.
go back to reference Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS Behav. 2010;24:2263–70.CrossRef Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS Behav. 2010;24:2263–70.CrossRef
18.
go back to reference Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–90.PubMedCrossRef
19.
go back to reference Elul B, Basinga P, Nuwagaba-Biribonwoha H, et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One. 2013;8:e53586.PubMedCentralPubMedCrossRef Elul B, Basinga P, Nuwagaba-Biribonwoha H, et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One. 2013;8:e53586.PubMedCentralPubMedCrossRef
20.
go back to reference Murphy RA, Sunpath H, Castilla C, et al. Second-line antiretroviral therapy: long-term outcomes in South Africa. J Acquir Immune Defic Syndr. 2012;61:158–63.PubMedCentralPubMedCrossRef Murphy RA, Sunpath H, Castilla C, et al. Second-line antiretroviral therapy: long-term outcomes in South Africa. J Acquir Immune Defic Syndr. 2012;61:158–63.PubMedCentralPubMedCrossRef
21.
go back to reference Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20:1053–6.PubMedCrossRef Nachega JB, Stein DM, Lehman DA, et al. Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20:1053–6.PubMedCrossRef
22.
go back to reference Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003;17:1369–75.PubMedCrossRef Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa. AIDS. 2003;17:1369–75.PubMedCrossRef
23.
go back to reference Thirumurthy H, Siripong N, Vreeman RC, et al. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS. 2012;26:2399–403.PubMedCentralPubMedCrossRef Thirumurthy H, Siripong N, Vreeman RC, et al. Differences between self-reported and electronically monitored adherence among patients receiving antiretroviral therapy in a resource-limited setting. AIDS. 2012;26:2399–403.PubMedCentralPubMedCrossRef
24.
go back to reference Gupta RK, Jordan MR, Sultan BJ, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012;380:1250–8.PubMedCentralPubMedCrossRef Gupta RK, Jordan MR, Sultan BJ, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet. 2012;380:1250–8.PubMedCentralPubMedCrossRef
25.
go back to reference Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit TF. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. Curr Opin HIV AIDS. 2013;8:19–26.PubMedCrossRef Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit TF. Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. Curr Opin HIV AIDS. 2013;8:19–26.PubMedCrossRef
27.•
go back to reference Peltzer K, Ramlagan S, Jones D, et al. Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial. SAHARA J. 2012;9:218–26. This randomised trial suggests that lay health workers are as effective as professional clinic staff for providing ARV adherence support. Another significant finding is that an increase in adherence-related information on its own was not enough to impact ARV adherence behaviour..PubMedCrossRef Peltzer K, Ramlagan S, Jones D, et al. Efficacy of a lay health worker led group antiretroviral medication adherence training among non-adherent HIV-positive patients in KwaZulu-Natal, South Africa: results from a randomized trial. SAHARA J. 2012;9:218–26. This randomised trial suggests that lay health workers are as effective as professional clinic staff for providing ARV adherence support. Another significant finding is that an increase in adherence-related information on its own was not enough to impact ARV adherence behaviour..PubMedCrossRef
28.
go back to reference Amico KR. Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th International Conference on HIV Treatment Adherence. J Int Assoc Physicians AIDS Care (Chic). 2011;10:291–6.CrossRef Amico KR. Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th International Conference on HIV Treatment Adherence. J Int Assoc Physicians AIDS Care (Chic). 2011;10:291–6.CrossRef
29.
go back to reference Schneider H, Hlophe H, van Rensburg D. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Policy Plan. 2008;23:179–87.PubMedCrossRef Schneider H, Hlophe H, van Rensburg D. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Policy Plan. 2008;23:179–87.PubMedCrossRef
30.
go back to reference Dewing S, Mathews C, Schaay N, et al. "It's Important to Take Your Medication Everyday Okay?" An Evaluation of Counselling by Lay Counsellors for ARV Adherence Support in the Western Cape. South Africa: AIDS and Behavior; 2012. Dewing S, Mathews C, Schaay N, et al. "It's Important to Take Your Medication Everyday Okay?" An Evaluation of Counselling by Lay Counsellors for ARV Adherence Support in the Western Cape. South Africa: AIDS and Behavior; 2012.
31.
go back to reference Myer L, Zulliger R, Pienaar D. Diversity of patient preparation activities before initiation of antiretroviral therapy in Cape Town, South Africa. Trop Med Int Health. 2012;17:972–7.PubMedCrossRef Myer L, Zulliger R, Pienaar D. Diversity of patient preparation activities before initiation of antiretroviral therapy in Cape Town, South Africa. Trop Med Int Health. 2012;17:972–7.PubMedCrossRef
32.
go back to reference Torpey KE, Kabaso ME, Mutale LN, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3:e2204.PubMedCentralPubMedCrossRef Torpey KE, Kabaso ME, Mutale LN, et al. Adherence support workers: a way to address human resource constraints in antiretroviral treatment programs in the public health setting in Zambia. PLoS One. 2008;3:e2204.PubMedCentralPubMedCrossRef
33.
go back to reference Ritzenthaler R. Delivering antiretroviral therapy in resource-constrained settings: Lessons from Ghana, Kenya and Rwanda. Arlington: Family Health International; 2005. Ritzenthaler R. Delivering antiretroviral therapy in resource-constrained settings: Lessons from Ghana, Kenya and Rwanda. Arlington: Family Health International; 2005.
34.
go back to reference Feldacker C, Johnson D, Hosseinipour M, Phiri S, Tweya H. Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi. PLoS One. 2012;7:e50871.PubMedCentralPubMedCrossRef Feldacker C, Johnson D, Hosseinipour M, Phiri S, Tweya H. Who starts? Factors associated with starting antiretroviral therapy among eligible patients in two, public HIV clinics in Lilongwe, Malawi. PLoS One. 2012;7:e50871.PubMedCentralPubMedCrossRef
35.
go back to reference Remien RH, Mellins CA, Robbins RN, et al. Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav. 2013;17:1979–91.PubMedCrossRef Remien RH, Mellins CA, Robbins RN, et al. Masivukeni: development of a multimedia based antiretroviral therapy adherence intervention for counselors and patients in South Africa. AIDS Behav. 2013;17:1979–91.PubMedCrossRef
36.
go back to reference Dean AL, Makin JD, Kydd AS, Biriotti M, Forsyth BW. A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa. J Telemed Telecare. 2012;18:399–403.PubMedCrossRef Dean AL, Makin JD, Kydd AS, Biriotti M, Forsyth BW. A pilot study using interactive SMS support groups to prevent mother-to-child HIV transmission in South Africa. J Telemed Telecare. 2012;18:399–403.PubMedCrossRef
37.
go back to reference Tirivayi N, Koethe JR, Groot W. Clinic-based food assistance is associated with increased medication adherence among HIV-infected adults on long-term antiretroviral therapy in Zambia. J AIDS Clin Res. 2012;3:171.PubMedCentralPubMedCrossRef Tirivayi N, Koethe JR, Groot W. Clinic-based food assistance is associated with increased medication adherence among HIV-infected adults on long-term antiretroviral therapy in Zambia. J AIDS Clin Res. 2012;3:171.PubMedCentralPubMedCrossRef
39.•
go back to reference Luque-Fernandez MA, Van Cutsem G, Goemaere E, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013;8:e56088. This study provides evidence for the effectiveness of a simplified model of care in which the management of ARV treatment is moved out of primary healthcare facilities and in to the community. This model can facilitate the expansion of ART programmes in SSA..PubMedCentralPubMedCrossRef Luque-Fernandez MA, Van Cutsem G, Goemaere E, et al. Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One. 2013;8:e56088. This study provides evidence for the effectiveness of a simplified model of care in which the management of ARV treatment is moved out of primary healthcare facilities and in to the community. This model can facilitate the expansion of ART programmes in SSA..PubMedCentralPubMedCrossRef
40.
go back to reference Medicines Sans Frontiers: ART Adherence Club Report and Toolkit. In: Medicines Sans Frontiers; 2012. Medicines Sans Frontiers: ART Adherence Club Report and Toolkit. In: Medicines Sans Frontiers; 2012.
41.•
go back to reference Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr. 2012;61:e50–8. This study shows that the large-scale implementation of a lay health worker delivered adherence support programme in South Africa has been effective in improving adherence outcomes. Strengths of this study include a 5 year follow-up and large sample size from 4 provinces..PubMedCrossRef Fatti G, Meintjes G, Shea J, Eley B, Grimwood A. Improved survival and antiretroviral treatment outcomes in adults receiving community-based adherence support: 5-year results from a multicentre cohort study in South Africa. J Acquir Immune Defic Syndr. 2012;61:e50–8. This study shows that the large-scale implementation of a lay health worker delivered adherence support programme in South Africa has been effective in improving adherence outcomes. Strengths of this study include a 5 year follow-up and large sample size from 4 provinces..PubMedCrossRef
42.
go back to reference Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011;6:e19201.PubMedCentralPubMedCrossRef Boyles TH, Wilkinson LS, Leisegang R, Maartens G. Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme. PLoS One. 2011;6:e19201.PubMedCentralPubMedCrossRef
43.
go back to reference Kranzer K, Lewis JJ, Ford N, et al. Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr. 2010;55:e17–23.PubMedCentralPubMedCrossRef Kranzer K, Lewis JJ, Ford N, et al. Treatment interruption in a primary care antiretroviral therapy program in South Africa: cohort analysis of trends and risk factors. J Acquir Immune Defic Syndr. 2010;55:e17–23.PubMedCentralPubMedCrossRef
44.
go back to reference Lyimo RA, de Bruin M, van den Boogaard J, et al. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. BMC Public Health. 2012;12:716.PubMedCentralPubMedCrossRef Lyimo RA, de Bruin M, van den Boogaard J, et al. Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective. BMC Public Health. 2012;12:716.PubMedCentralPubMedCrossRef
45.
go back to reference Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–8.PubMedCrossRef Weiser S, Wolfe W, Bangsberg D, et al. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003;34:281–8.PubMedCrossRef
46.
go back to reference Eholie SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2007;45:355–8.PubMed Eholie SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2007;45:355–8.PubMed
47.
go back to reference Uzochukwu BS, Onwujekwe OE, Onoka AC, et al. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan. 2009;24:189–96.PubMedCrossRef Uzochukwu BS, Onwujekwe OE, Onoka AC, et al. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Health Policy Plan. 2009;24:189–96.PubMedCrossRef
48.
go back to reference Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr J Public Health. 2008;5:74–8.PubMed Talam NC, Gatongi P, Rotich J, Kimaiyo S. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. East Afr J Public Health. 2008;5:74–8.PubMed
49.
go back to reference Byakika-Tusiime J, Crane J, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13 Suppl 1:82–91.PubMedCrossRef Byakika-Tusiime J, Crane J, et al. Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav. 2009;13 Suppl 1:82–91.PubMedCrossRef
50.
go back to reference Musumari PM, Feldman MD, Techasrivichien T, et al. "If I have nothing to eat, I get angry and push the pills bottle away from me": a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013. doi:10.1080/09540121.2013.764391.PubMed Musumari PM, Feldman MD, Techasrivichien T, et al. "If I have nothing to eat, I get angry and push the pills bottle away from me": a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013. doi:10.​1080/​09540121.​2013.​764391.PubMed
51.
go back to reference Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care. 2011;23:1246–53.PubMedCrossRef Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care. 2011;23:1246–53.PubMedCrossRef
52.
go back to reference Weiser SD, Tuller DM, Frongillo EA, et al. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5:e10340.PubMedCentralPubMedCrossRef Weiser SD, Tuller DM, Frongillo EA, et al. Food insecurity as a barrier to sustained antiretroviral therapy adherence in Uganda. PLoS One. 2010;5:e10340.PubMedCentralPubMedCrossRef
54.
go back to reference Dahab M, Charalambous S, Hamilton R, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63.PubMedCentralPubMedCrossRef Dahab M, Charalambous S, Hamilton R, et al. "That is why I stopped the ART": patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme. BMC Public Health. 2008;8:63.PubMedCentralPubMedCrossRef
55.
go back to reference Miller MM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15:48–54.PubMedCentralPubMedCrossRef Miller MM, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Trop Med Int Health. 2010;15:48–54.PubMedCentralPubMedCrossRef
56.
go back to reference Heffron R, Ngure K, Mugo N, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61:116–9.PubMedCentralPubMedCrossRef Heffron R, Ngure K, Mugo N, et al. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies. J Acquir Immune Defic Syndr. 2012;61:116–9.PubMedCentralPubMedCrossRef
57.
go back to reference Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13:63–9.PubMedCrossRef Haire B, Kaldor JM. Ethics of ARV based prevention: treatment-as-prevention and PrEP. Dev World Bioeth. 2013;13:63–9.PubMedCrossRef
58.
go back to reference Decroo T, Mondlane V, Dos Santos N, et al. Community ART groups support ART access and retention among HIV-positive dependent children in rural Tete, Mozambique (WEPE720). In: International AIDS Conference. Washington DC; 2012. Decroo T, Mondlane V, Dos Santos N, et al. Community ART groups support ART access and retention among HIV-positive dependent children in rural Tete, Mozambique (WEPE720). In: International AIDS Conference. Washington DC; 2012.
59.
go back to reference Dewing S, Mathews C, Cloete A, et al. From research to practice: lay adherence counsellors' fidelity to an evidence-based intervention for promoting adherence to antiretroviral treatment in the Western Cape, South Africa. AIDS Behav. 2013;17:2935–45.PubMedCrossRef Dewing S, Mathews C, Cloete A, et al. From research to practice: lay adherence counsellors' fidelity to an evidence-based intervention for promoting adherence to antiretroviral treatment in the Western Cape, South Africa. AIDS Behav. 2013;17:2935–45.PubMedCrossRef
61.
go back to reference Rodrigues R, Shet A, Antony J, et al. Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One. 2012;7:e40723.PubMedCentralPubMedCrossRef Rodrigues R, Shet A, Antony J, et al. Supporting adherence to antiretroviral therapy with mobile phone reminders: results from a cohort in South India. PLoS One. 2012;7:e40723.PubMedCentralPubMedCrossRef
62.
go back to reference Nash D, Korves C, Saito S, et al. Characteristics of Facilities and Programs Delivering HIV Care and Treatment Services Are Associated with Loss to Follow-up Rates in Programs from 7 Sub-Saharan African Countries. In: 15th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; 2008. Nash D, Korves C, Saito S, et al. Characteristics of Facilities and Programs Delivering HIV Care and Treatment Services Are Associated with Loss to Follow-up Rates in Programs from 7 Sub-Saharan African Countries. In: 15th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada; 2008.
63.
go back to reference Cantrell RA, Sinkala M, Megazinni K, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49:190–5.PubMedCrossRef Cantrell RA, Sinkala M, Megazinni K, et al. A pilot study of food supplementation to improve adherence to antiretroviral therapy among food-insecure adults in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2008;49:190–5.PubMedCrossRef
Metadata
Title
Antiretroviral Adherence Interventions in Southern Africa: Implications for Using HIV Treatments for Prevention
Authors
Sarah Dewing
Cathy Mathews
Geoffrey Fatti
Ashraf Grimwood
Andrew Boulle
Publication date
01-03-2014
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 1/2014
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-013-0193-5

Other articles of this Issue 1/2014

Current HIV/AIDS Reports 1/2014 Go to the issue

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Are Infants Unique in Their Ability to be “Functionally Cured” of HIV-1?

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Inflammatory Co-morbidities in HIV+ Individuals: Learning Lessons from Healthy Ageing

The Science of Prevention (SC Kalichman, Section Editor)

HIV Prevention Interventions for Young Male Commercial Sex Workers

HIV Pathogenesis and Treatment (AL Landay, Section Editor)

Practical Considerations in Gene Therapy for HIV Cure

The Science of Prevention (SC Kalichman, Section Editor)

Social Networks, Sexual Networks and HIV Risk in Men Who Have Sex with Men

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine